Recent evidence suggests that histone deacetylase (HDAC) inhibitors facilitate extinction of rewarding memory of drug taking. However, little is known about the role of chromatin modification in the extinction of aversive memory of drug withdrawal. In this study, we used conditioned place aversion (CPA), a highly sensitive model for measuring aversive memory of drug withdrawal, to investigate the role of epigenetic regulation of brain-derived neurotrophic factor (BDNF) gene expression in extinction of aversive memory. We found that CPA extinction training induced an increase in recruiting cAMP response element-binding protein ( 
Introduction
Opiate addiction is the chronic relapsing disorder characterized by compulsive drug taking (De Vries and Shippenberg, 2002) . Conditioned reinforcement may play a crucial role in loss of control over drug taking and relapse after abstinence. Increasing evidence shows that negative reinforcement resulting from the aversive affective consequences of opiate withdrawal can enhance the incentive value of the drug and contribute to the maintenance of drug seeking behavior (Hutcheson et al., 2001; Koob and Le Moal, 2005; Kenny et al., 2006) . Conditioned place aversion (CPA) is a highly sensitive animal model for measurement of the negative affective components of opiate withdrawal (Stinus et al., 2000; Azar et al., 2003) and it develops through associative learning and requires synaptic plasticity (Hou et al., 2009) . Extinction therapy has been proposed as a method to reduce the motivational impact of drug-associated cues to prevent relapse (Taylor et al., 2009 ). There is much information about the neurobiological mechanism of extinction of reward memory of drug taking (Feltenstein and See, 2007; Hsu and Packard, 2008; Torregrossa et al., 2010) . However, as yet little information is known about extinction of aversive memory of drug withdrawal (Myers and Carlezon, 2010) . Understanding the mechanisms underlying extinction of aversive memories of drug withdrawal could lead to pharmacological approaches for enhancing extinction memory, which might facilitate the treatment of drug addiction.
Extinction is a form of new learning that inhibits the original memory. Studies have suggested that the molecular mechanisms of extinction are similar to those that underlie initial associative learning (Quirk and Mueller, 2008) . Recent evidence suggests the regulation of transcription via chromatin modification appears to be a major molecular mechanism for the formation and/or consolidation of drug associated memories and may contribute to the formation and persistence of drug-seeking behaviors (Kumar et al., 2005; Levine et al., 2005; Renthal et al., 2007; Romieu et al., 2008; Malvaez et al., 2011) . Recent studies also suggest that epigenetic mechanisms have an important role in extinction of drug-seeking behaviors. It has been demonstrated that systematic administration of the histone deacetylase (HDAC) inhibitors following exposure to the previously drug-paired context facilitates extinction of drug-induced conditioned place preference (CPP) and reduces reinstatement of CPP after subsequent drug exposure Wang et al., 2010) . Although these two elegant studies demonstrate involvement of chromatin modification in extinction of positive affective memory of drug taking, little is known about epigenetic regulation of gene transcription in extinction of aversive memory associated with drug withdrawal.
Accumulating evidence indicates that the ventromedial prefrontal cortex (vmPFC) is critical for the extinction of fear and drug-seeking behaviors (Peters et al., 2009) . Recent evidence shows that epigenetic regulation of the gene encoding brainderived neurotrophic factor (BDNF) within the medial prefrontal cortex (mPFC) correlates with fear extinction (Bredy et al., 2007) and attenuating the reinforcing efficacy of cocaine (SadriVakili et al., 2010) . Accordingly, exogenous BDNF infusions into the mPFC suppress the reinstatement of cocaine seeking (Berglind et al., 2007 (Berglind et al., , 2009 McGinty et al., 2010; Whitfield et al., 2011) . These studies raise the possibility that epigenetic regulation of the gene encoding BDNF within the mPFC might be implicated in extinction of reward memory of drug taking or aversive memory of drug withdrawal. Therefore, this study used CPA paradigm to investigate the role of chromatin modification within vmPFC of BDNF mRNA expression in extinction of aversive affective memory associated with drug withdrawal.
Materials and Methods

Subjects
Sprague Dawley male rats weighing 220 -250 g were obtained from the Laboratory Animal Center, Chinese Academy of Sciences (Shanghai, China). Rats were housed three per cage and maintained on a 12 h light/ dark cycle with access to food and water ad libitum. All experimental procedures were in strict accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Surgery
Rats (weighing 270 -300 g when surgery began) were anesthetized with sodium pentobarbital anesthesia (55 mg/kg, i.p.), treated with atropine sulfate (0.2 mg/kg, i.p.) and then placed in a stereotaxic apparatus (Narishige). Rats were implanted bilaterally with guide cannulae in the ventromedial prefrontal cortex [anteroposterior (AP), ϩ2.8 mm; mediolateral (ML), Ϯ0.6 mm; dorsoventral (DV), Ϫ3.5 mm). The cannulas were anchored to the skull with stainless steel screws and dental cement. A stainless steel blocker was inserted into each cannula to keep them patent and prevent infection. The rats were allowed to recover from surgery for 3-5 d.
Intracerebral microinjection. Each infusion volume was 0.5 l per side infused at a rate of 0.25 l/min. Bilateral microinfusions were made through 31 gauge injection cannulae (1.0 mm beyond the tip of guide cannulae) that was connected to a 10 l microsyringe mounted in the microinfusion pump (Harvard Apparatus), and the drugs were infused into the vmPFC over 2 min and given an additional 2 min for drug diffusion.
U0126 (1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene) and Trichostatin A were bilaterally microinjected into the vmPFC 20 min before extinction; D-cycloserine, K252a and TrkB-FC were bilaterally injected into the vmPFC immediately after extinction training.
TrkB-FC was directly dissolved in PBS to a final concentration of 1.3 g/l; all other drugs were dissolved in 25% DMSO (10 mM stock solution) and diluted in PBS to a final concentration [aminophosphonopentanoic acid (AP-5), 10 g/l; U0126, 200 ng/l; D-cycloserine, 20 g/l; Trichostatin A, 330 M; K252a, 35.7 M).
The doses of U0126, D-cycloserine, Trichostatin A, K252a and TrkB-FC were chosen based on pilot experiments and previous studies (Walker et al., 2002; Li et al., 2008; Wang et al., 2010; Whitfield et al., 2011) .
Excitotoxic lesions. Rats were anesthetized using sodium pentobarbital (55 mg/kg, i.p.), treated with atropine sulfate (0.2 mg/kg, i.p.), and then placed in a stereotaxic apparatus (Narishige). The scalp was incised and retracted to expose the skull. Small burr holes were drilled through the skull to place a 26 gauge guide cannula using the following coordinates: (1) AP, ϩ2.8 mm, ML, Ϯ0.6 mm, DV, Ϫ4.5 mm; (2) AP, ϩ2.8 mm, ML, Ϯ0.6 mm, DV, Ϫ4.0 mm. Quinolinic acid (0.09 M) was infused in the vmPFC (0.4 l/site), over 2 min with a 31 gauge injection cannula (1.0 mm beyond the tip of guide cannula) that was connected to a 10 l microsyringe mounted in the microinfusion pump (Harvard Apparatus). After each infusion, the injection cannula was left in place for 4 min and then removed slowly. Rats in the sham group were given the same surgical procedures but did not receive microinfusion. All rats were given 5-7 d for postsurgical recovery before behavioral training.
Histology
After behavior testing, rats were deeply anesthetized with sodium pentobarbital and perfused transcardially with PBS, followed by 4% Formalin. The brains were removed and stored in a 30% sucrose solution for 2-3 d. Coronal sections (30 m thick) were cut on a cryostat (Leica), stained with cresyl violet, and then examined by light microscopy to determine lesion locations or injection sites.
Apparatus and procedures
The CPA apparatus [62 cm (length) ϫ 24 cm (width) ϫ 24 cm (height)] made of Plexiglas was divided into two equal-sized compartments by a removable partition with an opening (8 ϫ 8 cm) at one end, which allowed rats ad libitum access to each compartment. Two compartments were distinguished by visual (white or black) and tactile cue (bar or slick) and provided the distinct contexts that were paired with morphine or saline injections. The apparatus were equipped with infrared photobeams connected to a computer that recorded the rat's location in the chambers.
Training. To determine baseline place preference, the rats were initially placed in the apparatus with the doors removed for 15 min (preconditioning test). Conditioning was performed using an unbiased, counterbalanced protocol, as described in our previous work (Hou et al., 2009) . Thirty-three of the 389 rats that were tested for initial CPP preference showed a strong unconditioned aversion (Ͻ180 in any chamber) and therefore were excluded.
Conditioning took place over the next 2 d. On the first day, the rats were injected with saline (1 ml/kg, s.c.) and then returned to home cages. Four hours later, they were again given saline and then confined to either compartment in a counterbalanced manner for 30 min. On the second day, the rats were injected with morphine (10 mg/kg, s.c.) and then returned to their home cages. Four hours later, they were injected with naloxone (0.3 mg/kg, s.c.) and then confined to the compartment opposite to that on the first day for 30 min. This compartment will be referred to as the "drug treatment-paired compartment." In the post-training testing phase (24 h after the conditioning trial), all rats were allowed to freely explore the entire apparatus for 15 min, and the amount of time spent in each compartment was recorded. CPA score represents the time in the drug treatment-paired compartment during the testing phase minus that during the preconditioning phase.
Extinction. The experiments were performed as described previously (Myers and Carlezon, 2010) with little modification. Briefly, extinction training began 24 h after the post-training test and consisted of 30 min confinements in the previously naloxone-paired compartment. On each confinement day, the order of exposure was counterbalanced across rats and reversed relative to the preceding session. Saline was administered immediately before each confinement. Three confinement days were conducted and a 15 min extinction test was performed 24 h after each confinement day. The rats were decapitated 30 min after the last test.
Tissue sample preparation and Histone extraction
Brains were rapidly removed, frozen in liquid nitrogen, and stored in a Ϫ80°C freezer before dissection. Coronal brain sections (1 mm thick) were obtained using a rat brain slicer (Braintree Scientific). The infralimbic (IL) subdivisions of the vmPFC from both hemispheres of rats was isolated from brain slices using a blunt-end, 17 gauge syringe needle (1 mm inner diameter), as described previously (Li et al., 2008) . Most rats were decapitated at different time points with anesthesia after the end of the 30 min extinction training. Rats in the control conditions were decapitated at the corresponding time just without receiving extinction training. Tissue punches were homogenized (10 -15 s for three times, 5 s interval) with a sonicator (Sonics & Materials) in 300 l of lysis buffer (containing, in mM: 20 Tris, pH 7.5, 150 NaCl, 1% Triton X-100, 2.5 sodium pyrophosphate, 1 EDTA, 1% Na 3 VO 4 , 0.5 g/ml leupeptin, and 1 phenylmethanesulfonyl fluoride; Beyotime Biotechnology). Then, the tissue homogenates were subjected to 10,000 ϫ g centrifugation at 4°C for 10 min. The nuclear protein CBP (CREB binding protein) extractions were prepared according to the method of Dignam et al. (1983) . The protein concentrations of all samples were determined using the bicinchoninic acid assay (Beyotime Biotechnology). Samples were further diluted in radioimmunoprecipitation assay lysis buffer to equalize the protein concentrations.
Histone extraction was performed as described previously (Roozendaal et al., 2010) . Briefly, tissue was homogenized in a hypotonic lysis buffer (containing, in mM: 10 Tris, pH 8.0, 1 EDTA, 2.5 sodium pyrophosphate, 1 sodium orthovanadate, 1 PMSF, and 1% Halt Protease Cocktail Inhibitor) in 1.5 ml Eppendorf tubes. Lysates were then centrifuged at 14 relative centrifugal force (RCF) for 30 min at 4°C. The supernatant was collected, leaving the nuclear pellet for acid extraction (1 ml of 0.4 M H 2 SO 4 ). The nuclear pellet and acid buffer were placed on ice for 20 min and then centrifuged at 14 RCF for 30 min at 4°C. Next, the acid supernatant was collected and ice-cold acetone was added to the pellet and placed on ice for 10 min before being centrifuged at 14 RCF for 30 min at 4°C. Finally, the supernatant was removed and remaining histone pellet was placed at room temperature for 5 min (for remaining acetone to evaporate) before being resuspended in 9 M urea.
Western blot assays
For Western blot analysis, tissue samples and histone extracts from dissected rat vmPFC were used, and the experiments were performed as described previously (Li et al., 2008) . Briefly, four times loading buffer (16% glycerol, 20% mercaptoethanol, 2% SDS, and 0.05% bromophenol blue) was added to each sample (3:1; sample: loading buffer) before boiling for 10 min. Samples were cooled and subjected to SDS-PAGE for ϳ30 min at 80 V in stacking gel and ϳ1 h at 120 V in resolving gel, after which proteins were transferred to polyvinylidene difluoride membranes for immunoblotting. For each electrophoresis, increasing amounts of protein pooled from all samples were electrophoresed to produce a standard curve. Proteins were transferred electrophoretically to Immobilon-P transfer membranes (Millipore). Membranes were washed with TBST (Tris-buffered saline plus 0.05% Tween 20, pH 7.4) and then dipped in blocking buffer (5% skimmed dry milk in TBST) 1 h at room temperature on orbital shaker. The membranes were incubated overnight at 4°C with various primary antibodies that included the following: anti-pERK, anti-ERK antibody (Santa Cruz Biotechnology), anti-pCREB, anti-CBP and anti-CREB (Millipore) at a dilution of 1:4000, anti-acetylated histone H3 Lys 9 and anti-acetylated histone H4 Lys 8 antibody (Millipore) at a dilution of 1:1000, anti-actin and anti-GAPDH antibody (Sigma) at a dilution of 1:10,000 and then incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. Immunolabeling of membranes was detected via chemiluminescence (ECL, GE Healthcare; SuperSignal, Pierce). Excess mix was dripped off before blots were wrapped with a clean piece of Saran Wrap (no bubbles between blot and wrap) and then exposed against x-ray film (Eastman Kodak) for 5-60 s. The immunopositive signals were quantified by Quantity One software (Bio-Rad).
Chromatin immunoprecipitation and quantitative real-time PCR
Chromatin immunoprecipitation (ChIP) was performed following a modification of the Millipore Biotechnology ChIP kit protocol. The infralimbic cortex from both hemispheres of rats was isolated from brain slices as described previously. The tissue was then incubated in 1% formaldehyde in PBS at room temperature for 20 min, and then the reaction was stopped by adding glycine to a final concentration of 0.125 M. The tissue was washed 3 times with an ice-cold PBS containing protease inhibitors (PIs) (Complete Mini Protease Inhibitor Cocktail tablets; Roche). Tissue was homogenized in cell lysis buffer (10 mM Tris, 10 mM NaCl, and 0.2% NP-40). The homogenate was centrifuged at 5500 ϫ g for 10 min. The supernatant, containing extracellular debris, was decanted, and the pellet was homogenized in SDS lysis buffer with PIs and phosphorylase inhibitors. Next, the extracted chromatin was sheared to 200ϳ1000 bp using the VibraCell sonicator. Lysates were centrifuged at 12,000 ϫ g for 10 min to pellet debris and then diluted 1:10 in ChIP dilution buffer. Extracts were precleared for 60 min with 35 l of 50% suspension of salmon sperm saturated protein A. A total of 10 l of the preimmunoprecipitated lysate was saved as "input." Immunoprecipitations were performed at 4°C overnight with primary antibodies (antiacetyl H3, anti-acetyl H4, anti-p-CREB, normal mouse IgG, normal rabbit IgG) or no antibody (control). Immune complexes were collected with 60 l of salmon sperm DNA/protein A-agarose beads at 4°C for 1 h. The beads were sequentially washed once with low salt, high salt, and LiCl and washed twice with Tris-EDTA buffers. Immune complexes were eluted from the beads by 200 l of NaHCO 3 /SDS elution buffer and protein-DNA crosslinks were reverted by heating at 65°C for 4 h. After proteinase K digestion (1.5 h at 45°C), immunoprecipitated DNA was extracted by the DNA extraction columns provided in the kits, and input DNA was extracted by using a QIAquick PCR purification kit. Immunoprecipitated DNA was subjected to quantitative real-time PCR using primers specific to the rat BDNF promoters. C t values of each sample and its corresponding input were used to calculate IP DNA quantities as the percentage of input using the following equation: ChIP DNA as a % of input ϭ 2 (⌬Ct) . Quantitative real-time PCR was performed in an Opticon2 (Bio-Rad MJ Research) using SYBR Green PCR Master Mix (Cowin) through 45 PCR cycles (95°C for 10 s, 60°C for 45 s). The threshold cycle for each sample was chosen from the linear range and converted to a starting quantity by interpolation from a standard curve run on the same plate for each set of primers. The mRNA levels were normalized for each well to the GAPDH mRNA levels. Single PCR products were verified by assessing that the melting temperature of the product had a single value.
PrimersusedintheChIPassaywere:BDNFP1,5Ј-TGATCATCACTCACGA CCACG-3Ј, 5Ј-CAGCCTCTCTGAGCCAGTTACG-3Ј; BDNF P4, 5Ј-AAAG CATGCAATGCCCT-3Ј, 5Ј-GAGATTTCATGCTAGCTCGC-3Ј; BDNF exon I, 5Ј-CTCAAAGGGAAACGTGTCTCT-3Ј, 5Ј-TCACGTGCTCAAAAGTGT CAG-3Ј; BDNF exon IV, 5Ј-TGCGAGTATTACCTCCGCCAT-3Ј; 5Ј-TCAC GTGCTCAAAAGTGTCAG-3Ј; GAPDH, 5Ј-AACGACCCCTTCATTGAC-3Ј, 5Ј-TCCACGACATACTCAGCAC-3Ј.
Data analysis
The data were analyzed with one-or two-way ANOVA followed by Bonferroni's post hoc tests or Student's t tests, when appropriate. Differences with p Ͻ 0.05 were considered statistically significant. The results are presented as mean Ϯ SEM.
Results
Lesions of the vmPFC of rats block extinction of morphine withdrawal-induced conditioned place aversion
Lesion and pharmacological manipulation studies show that the vmPFC is critical for the storage and recall of extinction memories (Milad and Quirk, 2002; Phelps et al., 2004) . To determine whether vmPFC is also necessary for extinction of aversive memories associated with morphine withdrawal, we examined the effects of bilateral excitotoxic lesions of vmPFC with quinolinic acid on extinction of CPA behavior. As shown in Figure 1 A, rats with bilateral excitotoxic lesions of vmPFC showed much higher CPA scores than sham-lesion rats, indicating impairment of extinction. Twoway ANOVA assays revealed the significant main effect of extinction training (No-ext vs Ext: F (1,39) ϭ 11.68, p Ͻ 0.01) and lesions (Sham vs Lesion: F (3,39) ϭ 11.45, p Ͻ 0.001), as well as a significant interaction between these factors (F (3,39) ϭ 3.49, p Ͻ 0.05). The following post hoc test showed that there was significant difference in CPA scores between lesion-extinction rats and shamextinction rats ( p Ͻ 0.05 for Test 1, p Ͻ 0.01 for Test 2 and 3). These results demonstrate that the vmPFC is required for extinction of aversive memories associated with morphine withdrawal. Figure  1 B shows schematic illustrations of lesion areas in 15 of the rats that received bilateral infusion of quinolinic acid into the vmPFC. Guide cannulas were centered on the IL subdivision of the vmPFC.
CPA extinction training activates ERK and CREB in the vmPFC and intra-vmPFC injection of U0126 prevents activation of ERK and CREB and disrupts extinction of CPA behavior ERK (extracellular signal-regulated kinase) activation has been described in different brain regions with several learning paradigms (Atkins et al., 1998; Blum et al., 1999; Schafe et al., 2000) and is involved in activity-dependent modulation of synaptic plasticity in various brain areas (English and Sweatt, 1997; Huang et al., 2000) , including the mPFC (Otani et al., 1999) . ERK inhibitors have been shown to block acquisition in a variety of learning paradigms, including extinction learning (Lu et al., 2001; Hugues et al., 2004; Herry et al., 2006) . Thus, we determined whether ERK activation in the vmPFC was involved in the extinction of aversive memories associated with drug withdrawal. To do this, we measured the levels of ERK phosphorylation (pERK) in the vmPFC following extinction training. As shown in Figure 2 A, a significant increase of pERK in the vmPFC was detected at 1 h after extinction. One-way ANOVA assays revealed a significant main effect of extinction training (Mor vs Mor-Ext: F (3,19) ϭ 7.99, p Ͻ 0.01). The following Bonferroni post hoc test showed a significant difference between treatments for pERK ( p Ͻ 0.01). Increase of pERK by extinction training was time-dependent (Fig.  2 B) . One-way ANOVA followed by Bonferroni post hoc test also showed that there were significant differences in pERK between 0.5 h (p Ͻ 0.001), 1 h (p Ͻ 0.05), and 2 h (p Ͼ 0.05) after extinction training. cAMP response element-binding protein (CREB) is an important downstream factor of ERK (West et al., 2001) and plays a crucial role in ERK-mediated synaptic plasticity and long-term memories (Yin et al., 2002; Chwang et al., 2007) . Next, we examined the effect of extinction training on CREB activation (phosphorylation at serine 133). As shown in Figure  2C , a significant increase in phosphorylation of CREB (pCREB) was also detected in the vmPFC at 0.5 and 1 h after extinction training ( p Ͻ 0.05, p Ͻ 0.001, one-way ANOVA followed by Bonferroni post hoc test). Intra-vmPFC injection of ERK inhibitor U0126 before extinction training with a dose of 200 ng/l attenuated extinction training-induced phosphorylation of both ERK (t (1,10) ϭ 3.11, p Ͻ 0.05, Student's t test) and CREB (t (1,10) ϭ 2.62, p Ͻ 0.05, Student's t test; Fig. 2 D) . Accordingly, intravmPFC injection of same dose of ERK inhibitor U0126 before extinction training also impaired extinction of CPA behavior (Fig. 2 E) . Two-way ANOVA assays revealed the significant main effect of extinction training (F (3,51) ϭ 8.50, p Ͻ 0.01) and drug treatment (F (1,51) ϭ 8.02, p Ͻ 0.05), as well as a significant interaction between these two factors (F (3,51) ϭ 4.17, p Ͻ 0.05). The following Bonferroni post hoc test showed a significant increase of CPA scores compared with vehicle-injected control group ( p Ͻ 0.05). Figure 2 F illustrates the microinjection tips located in the vmPFC. Together, these results suggest that activation of ERK-CREB pathway in vmPFC may be involved in the consolidation of extinction of CPA.
Intra-vmPFC injections of D-cycloserine facilitate extinction of CPA behavior and potentiate ERK and CREB activation D-Cycloserine (DCS), a NMDA receptor partial agonist, has been shown to facilitate extinction of CPA behavior (Myers and Carlezon, 2010) . To further confirm whether activation ERK and CREB in the vmPFC is required for extinction of CPA behavior, we determined whether facilitating extinction of CPA behavior by DCS was correlated with activation of ERK and CREB. Toward this end, we first examined the effect of DCS on extinction of CPA behavior in our CPA animal model. As shown in Figure 3A , intravmPFC injections of DCS (20 g/l) immediately after extinction training significantly facilitated extinction of CPA behavior. Two-way ANOVA assays revealed the significant main effect of extinction training (F (1,16) ϭ 51.56, p Ͻ 0.01) and drug treatment (F (1,16) ϭ 6.20, p Ͻ 0.05), as well as a significant interaction between these two factors (F (1,16) ϭ 5.68, p Ͻ 0.05). The following post hoc test showed a significant decrease of CPA scores compared with vehicle-injected control group ( p Ͻ 0.05). To further confirm that NMDA receptor signaling is important for extinction of CPA, we detected the effect of AP-5, a selective NMDAR antagonist, on extinction of CPA behavior. As shown in Figure  3C , intra-vmPFC injection of AP-5 (10 g/l) before extinction training significantly blocked extinction of CPA behavior. Twoway ANOVA assays revealed the significant main effect of extinction training (F (3,33) ϭ 12.51, p Ͻ 0.01) and drug treatment (F (1,33) ϭ 6.28, p Ͻ 0.05), as well as a significant interaction between these two factors (F (3,33) ϭ 5.54, p Ͻ 0.01). The following Bonferroni post hoc test showed a significant increase of CPA scores compared with vehicle-injected control group ( p Ͻ 0.01). To determine whether facilitating extinction of CPA by DCS is involved in activation of ERK and CREB, we examined the effects of intra-vmPFC injections of DCS and AP-5 on ERK and CREB phosphorylation in the vmPFC. Intra-vmPFC injections of DCS (20 g/l) immediately after extinction training significantly potentiated extinction-induced increases in the levels of pERK (t (1,10) ϭ 3.09, p Ͻ 0.01, Student's t test) and pCREB (t (1,10) ϭ 2.82, p Ͻ 0.05, Student's t test) in the vmPFC compared with vehicle-injected control groups (Fig. 3E) . By contrast, intravmPFC injections of AP-5 (10 g/l) before extinction training significantly decreased extinction-induced increases in the levels of pERK (t (1,10) ϭ 3.77, p Ͻ 0.01, Student's t test) and pCREB (t (1,10) ϭ 4.14, p Ͻ 0.01, Student's t test) in the vmPFC (Fig. 3F ) . Next, we examined the effects of U0126 on DCS-induced increases in pERK and pCREB. Increases in pERK and pCREB by DCS were significantly inhibited by intra-vmPFC injections of U0126 (200 ng/l) before extinction training (Fig. 3G,H ) . Oneway ANOVA assays revealed the significant main effects of pERK (F (2,17) ϭ 20.20, p Ͻ 0.001) and pCREB (F (2,17) ϭ 34.93, p Ͻ 0.001). The following Bonferroni post hoc test showed a significant decreases of pERK and pCREB compared with DCS treatment alone ( p Ͻ 0.05). This is consistent with previous findings that DCS facilitates consolidation of extinction fear memory in an ERK-dependent manner (Ledgerwood et al., 2003; Yang and Lu, 2005) . These results suggest that activation of ERK and CREB is involved in facilitating extinction of CPA behavior by DCS, supporting the notion that activation of ERK and CREB is essential for extinction of CPA behavior.
CPA extinction training increases acetylation of histone H3 and H4, and CBP expression in the vmPFC and the augmentation of histone acetylation are potentiated by intravmPFC injections of D-cycloserine Many forms of learning, including extinction, are dependent on changes in gene expression (Sangha et al., 2003; Lattal et al., 2006) . Epigenetic modification of chromatin has been proposed to play a crucial role in regulating gene expression (Levenson and Sweatt, 2005) . Previous studies showed that ERK regulated histone acetylation in hippocampus through activation of CREB (Levenson et al., 2004; Chwang et al., 2006; Chandramohan et al., 2008) . To further elucidate the mechanisms underlying the extinction of CPA behavior, we asked whether activation of ERK and CREB in the vmPFC induced chromatin modifications. Toward this end, we detected the effects of CPA extinction training Figure 2 . CPA extinction training increased ERK and CREB phosphorylation in the vmPFC, and intra-vmPFC injections of ERK inhibitor U0126 inhibited extinction training-induced ERK and CREB phosphorylation and impaired extinction of CPA behavior. A, Increase in ERK phosphorylation could be detected only in extinction of conditioned morphine withdrawal rats but not in other control group rats. B, C, Time courses of extinction training-induced ERK and CREB phosphorylation in the vmPFC. D, Intra-vmPFC injections of U0126 before extinction training suppressed extinctioninduced ERK and CREB phosphorylation. E, Intra-vmPFC injections of U0126 before extinction training blocked extinction of CPA behavior. F, Schematic representation of injection sites in the vmPFC for rats used in the experiments (OE, U0126; F, Vehicle). Values are expressed as mean Ϯ SEM (n ϭ 6 -8). *p Ͻ 0.05, **p Ͻ 0.01, compared with the no-extinction groups, one-way ANOVA followed by Bonferroni's post hoc test or Student's t test. Sal, Saline; Mor, morphine; Sal-Ext, saline-extinction; Mor-Ext, morphine-extinction.
on histone acetylation in the vmPFC and determined whether these effects could be suppressed by U0126. Extinction training increased acetylation of histone H3 at 1, 2, and 3 h (p Ͻ 0.01, p Ͻ 0.01 and p Ͻ 0.05, respectively, one-way ANOVA followed by Bonferroni post hoc test) and histone H4 at 1 and 2 h (p Ͻ 0.01, one-way ANOVA followed by Bonferroni post hoc test; Fig.  4 A, B) . Intra-vmPFC injections of U0126 before extinction training with a dose of 200 ng/l inhibited extinction traininginduced acetylation of histone H3 (t (1, 8) Fig. 4C ). CREB has been shown to induce histone acetylation through the coactivator CBP and its associated histone acetyltransferase activity (Vecsey et al., 2007) . To examine whether or not increased histone acetylation may be related to the enhanced function of CBP, we determined the protein levels of CBP in the vmPFC following extinction training. As shown in Figure 4 D, CPA extinction training significantly increased the protein levels of CBP in the vmPFC at 1 and 2 h compared with no-extinction groups ( p Ͻ 0.001, p Ͻ 0.05, respectively, one-way ANOVA followed by Bonferroni post hoc test).
Since DCS potentiates extinction-induced ERK activation, we next examined the effect of DCS on extinction-induced histone acetylation. As shown in Figure 4 E, intra-vmPFC injections of DCS immediately after extinction training with a dose of 20 g/l potentiated extinction-induced acetylation of histones H3 (t (1,10) ϭ 4.23, p Ͻ 0.01, Student's t test) and H4 (t (1,10) ϭ 3.76, p Ͻ 0.01, Student's t test) and these effects were reversed by intra-vmPFC injections of U0126 before extinction training (Fig.   4 F, G) . One-way ANOVA assays revealed the significant main effects acetylation of histone H3 (F (2,17) ϭ 6.00, p Ͻ 0.05) and acetylation of histone H4 (F (2,17) ϭ 13.11, p Ͻ 0.05). The following Bonferroni post hoc test showed a significant decreases of acetylation of histone H3 and H4 compared with treatment with DCS alone ( p Ͻ 0.05). Overall, these results indicate that extinction of CPA is implicated in chromatin modification in the vmPFC in an ERK signaling-dependent manner.
ChIP assays showed a selective increase in acetylation of histones H3 but not H4 at and the recruitment of CREB to the promoters of BDFN exon I-but not exon IV-containing transcript in the vmPFC during extinction of CPA BDNF is critical for learning related synaptic plasticity (Thoenen, 1995; Poo, 2001 ) and required for extinction of fear memory (Chhatwal et al., 2006; Bredy et al., 2007; Peters et al., 2010) . Recently, it was reported that increase of histone acetylation at BDNF gene promoters in prefrontal cortex were associated with extinction of conditioned fear (Bredy et al., 2007) . Since CPA extinction training induced acetylation of histone H3 and histone H4 (AcH3 and AcH4) in the vmPFC (Fig. 4) , we asked whether such chromatin modifications occurred at the promoters of BDNF genes. The rat BDNF gene consists of four distinct exons (Timmusk et al., 1993) and each of these exons is regulated by a specific promoter that is sensitive to epigenetic modification (Kumar et In the mPFC, exon I and IV-containing BDNF transcripts were shown to be responsive to epigenetic regulation following fear extinction (Bredy et al., 2007) . It was also reported that the phosphorylated CREB bound to exon IV to stimulate BDNF gene transcription in the mPFC (Sadri-Vakili et al., 2010) . Therefore, we used ChIP to assess the association of AcH3 and AcH4 with exon I and IV-containing BDNF transcripts in the vmPFC from rats that underwent extinction training. ChIP assays revealed that there was an increase in the association of AcH3 but not AcH4 with BDNF exon I-but not BDNF exon IV-containing transcript in the vmPFC after extinction training (Fig. 5 A, B) . Analysis of these data with two-way ANOVA revealed significant main effects of treatment (with or without extinction) (F (1,16) ϭ 14.88, p Ͻ 0.01) and exon (F (1,16) ϭ 8.36 p Ͻ 0.05), as well as a significant treatment ϫ exon interaction (F (1,16) ϭ 8.30, p Ͻ 0.05). The following Bonferroni's post hoc tests showed that there was a significant difference between with or without extinction for exon I.
CREB is an important transcription factor that modulates the transcription of many genes, including BDNF (Tao et al., 1998; Sadri-Vakili et al., 2010) . Several studies have demonstrated that CREB modulates gene transcription through acetylation of histone in a CBP-dependent manner (Levine et al., 2005; Chwang et al., 2007; Vecsey et al., 2007) . Given activation of CREB and increases in CBP expression by CPA extinction training, we hypothesized that extinction-induced acetylation of histone H3 at the promoter region of BDNF was involved in recruiting pCREB. To test this hypothesis, we used ChIP to assess the association of pCREB with BDNF exon I-and IV-containing transcripts in the vmPFC of rats after extinction training. As shown in Figure 5C , extinction training increased pCREB association with BDNF exon I-, but not with exon IVcontaining transcripts in the vmPFC, consistent with association of AcH3 with BDNF exon I-, but not with exon IV-containing transcripts. Two-way ANOVA assays revealed significant main effects of extinction (F (1,13) ϭ 5.81, p Ͻ 0.05) and exon (F (1,13) ϭ 8.4, p Ͻ 0.05), as well as a significant extinction ϫ exon interaction (F (1,13) ϭ 17.84, p Ͻ 0.001). Subsequent pairwise comparisons ( p Ͻ 0.001) showed a significant difference between two treatments for exon I.
Next, we assessed BDNF exon I and IV mRNA expression in the vmPFC of rats that underwent extinction training by using real-time PCR. As shown in Figure 5D , CPA extinction training resulted in a significant increase in BDNF exon I but not exon IV transcription in the vmPFC. Two-way ANOVA analyses revealed significant main effects of extinction treatment (F (1,5) ϭ 6.64, p Ͻ 0.05) and exon (F (1,5) ϭ 50.27, p Ͻ 0.001), as well as a significant interaction between the treatment and exon (F (1,5) ϭ 48.30, p Ͻ 0.001). The following Bonferroni's post hoc tests showed that there was a significant difference between with extinction and without extinction control groups for exon I ( p Ͻ 0.01).
Intra-vmPFC injection of ERK inhibitor U0126 attenuates the association of AcH3 as well as pCREB with BDNF exon Icontaining transcript and the enhancement of BDNF exon I transcription
Data mentioned above demonstrated that intra-vmPFC injections of U0126 disrupted extinction training-induced phosphorylation of CREB and acetylation of histone H3 in the mPFC. Thus, we examined the effects of intra-vmPFC injections of U0126 on extinction training-induced the association of AcH3 as well as pCREB with BDNF exon I-containing transcript and the enhancement of BDNF exon I transcription. As shown in Figure  6 A, intra-vmPFC injections of U0126 with a dose of 200 ng/l before extinction training robustly inhibited the association of AcH3 with BDNF exon I-containing transcript. Two-way ANOVA assays revealed significant main effects of drug treatment (F (1,15) ϭ 5.91, p Ͻ 0.05) and exon (F (1,15) ϭ 20.28, p Ͻ 0.001), as well as a significant treatment ϫ exon interaction (F (1,15) ϭ 7.75, p Ͻ 0.05). The following Bonferroni's post hoc tests showed that there was a significant difference between U0126 and Vehicle treatment for BDNF exon I-containing transcript ( p Ͻ 0.01).
Likewise, intra-vmPFC injection of U0126 with a dose of 200 ng/l before extinction training also robustly inhibited association of pCREB with BDNF exon I-containing transcript (Fig. 6 B) . Two-way ANOVA assays revealed significant main effects of drug treatment (F (1,12) ϭ 10.29, p Ͻ 0.01) and exon (F (1,12) ϭ 6.35, p Ͻ 0.05), as well as a significant extinction ϫ exon interaction (F (1,12) ϭ 7.00, p Ͻ 0.05). Subsequent pairwise comparisons ( p Ͻ 0.01) showed a significant difference between U0126 and Vehicle treatments for exon I-containing transcript. Paralleling its inhibitory effects on the association of AcH3 as well as pCREB with BDNF exon I-containing transcript, intra-vmPFC injections of U0126 with a dose of 200 ng/l before extinction training robustly inhibited enhancement of BDNF exon I transcription (Fig. 6C) . Two-way ANOVA revealed significant main effects of drug treatment (F (1,13) ϭ 6.75, p Ͻ 0.05) and exon (F (1,13) ϭ 16.91, p Ͻ 0.01), as well as a significant interaction between the treatment and exon (F (1,13) ϭ 16.91, p Ͻ 0.01). The following Bonferroni's post hoc tests showed a significant difference between U0126 and Vehicle treatments for exon I ( p Ͻ 0.001).
Intra-vmPFC injections of histone deacetylase inhibitor trichostatin A facilitate extinction of CPA behavior and potentiate extinction-induced histone acetylation and BDNF exon I transcription in the vmPFC
Recent research indicates that HDAC inhibitors facilitate extinction of fear memory (Bredy et al., 2007; Lattal et al., 2007) . To further confirm the involvement of changes in histone acetylation in regulation of BDNF mRNA expression and in extinction of CPA behavior, we tested the effects of intra-vmPFC injections of the HDAC inhibitor trichostatin A (TSA) on extinctioninduced histone acetylation and BDNF gene transcription in the vmPFC and on extinction of CPA behavior. We first detected the effect of intra-vmPFC injection of TSA (330 M) on extinctioninduced histone acetylation. As shown in Figure 7A , local injection of TSA (165 m/l) 20 min before extinction training significantly increased extinction-induced acetylation of histone H3 (t (1,10) ϭ 11.83, p Ͻ 0.001, Student's t test) and histone H4 (t (1,10) ϭ 10.96, p Ͻ 0.001, Student's t test) compared with vehicle injection. Next, we assessed the effect of intra-vmPFC injection of TSA on extinction-induced BDNF exon I and IV mRNA expression with the real time PCR. Local injection of TSA before extinction training also significantly potentiated BDNF exon I and IV mRNA expressions compared with local vehicle injection ( p Ͻ 0.001, p Ͻ 0.05, two-way ANOVA followed by Bonferroni post hoc test; Fig. 7B ). Accordingly, behavioral experiments showed that intra-vmPFC injection of TSA (330 M) before extinction training facilitated extinction of CPA behavior (Fig. 7C) . Twoway ANOVA assays revealed the significant main effect of extinction training (F (1,18) ϭ 48.64, p Ͻ 0.05) and drug treatment (F (1,18) ϭ 11.61, p Ͻ 0.01), as well as a significant interaction between these two factors (F (1,18) ϭ 4.59, p Ͻ 0.05). The following Bonferroni post hoc test showed a significant decrease of CPA scores compared with vehicle-injected control group ( p Ͻ 0.05). Figure 7D illustrated the microinjection tips located in the vmPFC. These results support that the chromatin modificationmediated increase in expression of BDNF gene in the vmPFC contributes to extinction of CPA behavior. Role of enhancement of BDNF protein expression in the vmPFC in extinction of CPA behavior Because BDNF and its receptor TrkB are known to regulate neuronal structure and function and are important for synaptic plasticity (Thoenen, 1995; Poo, 2001 ) and learning and memory, including fear extinction (Rattiner et al., 2004; Chhatwal et al., 2006; Heldt et al., 2007; Peters et al., 2010) , we hypothesized that epigenetic regulation within the vmPFC of BDNF gene expression was necessary for extinction of CPA behavior and that if true, it should be possible to inhibit CPA extinction via direct application of TrkB receptor antagonist K252a and BDNF scavenger TrkB-Fc to block BDNF signaling. To test this hypothesis, we first assessed BDNF protein expression in the vmPFC in response to extinction training. As shown in Figure 8 A, extinction training significantly increased BDNF protein expression at 1 h, 2 and 3 h ( p Ͻ 0.05, one-way ANOVA followed by Bonferroni post hoc test), consistent with the enhancement of BDNF mRNA expression in the vmPFC by extinction training. To determine whether increase in BDNF protein levels in the vmPFC were responsible for extinction of CPA behavior, we tested the effects of intravmPFC injections of K252a which is a tyrosine kinase inhibitor with high affinity for all Trk receptors and BDNF scavenger TrkB-Fc on extinction of CPA behavior. As shown in Figure 8 B, immediately after extinction training intra-vmPFC injection of K252a (35.7 M/l) impaired extinction of CPA behavior. Twoway assays revealed significant main effects of k252a treatment (F (1,39) ϭ 6.22, p Ͻ 0.05) and extinction training (F (3,39) ϭ 23.27, p Ͻ 0.001), as well as a significant k252a treatment ϫ test time interaction (F (3,39) ϭ 14.84, p Ͻ 0.001). Figure 8C illustrated the microinjection tips located in the vmPFC. Since K252a, a Trkselective tyrosine kinase inhibitor, is not specific for TrkB receptors, we thus further examined the effect of the BDNF scavenger TrkB-Fc on extinction of CPA behavior. Similarly, local injection of TrkB-Fc (1.3 g/l) into the vmPFC immediately after extinction training also significantly impaired extinction of CPA behavior (Fig. 8 D) . Two-way ANOVA assays revealed significant main effects of TrkB-Fc treatment (F (1,45) ϭ 5.08, p Ͻ 0.05) and extinction test times (F (3,45) ϭ 13.40, p Ͻ 0.001), as well as a significant interaction between TrkB-Fc treatment and extinction test times (F (3,45) ϭ 2.92, p Ͻ 0.05). Figure 8 E illustrates the microinjection tips located in the vmPFC. Together, these results indicate that increase in BDNF protein expression in the vmPFC plays a crucial role in extinction of CPA behavior.
Discussion
CPA extinction training results in epigenetic regulation within the vmPFC of BDNF gene transcription Long-lasting extinction of positive affective memory of drug taking and negative affective memory of drug withdrawal may be important for clinical treatment of drug addiction. Persistent extinction of conditioned responses depends on regulated gene expression (Sangha et al., 2003; Santini et al., 2004; Lattal et al., 2006) . Chromatin modification, such as histone acetylation, appears to be a critical mechanism involved in the regulation of gene transcription that may underlie long-term memory formation and longlasting changes in behaviors (Alarcó n et al., 2004; Levenson et al., 2004; Renthal and Nestler, 2008) . Recent research indicates that HDAC inhibitors facilitate extinction of fear memory (Bredy et al., 2007; Lattal et al., 2007; Bredy and Barad, 2008) and druginduced conditioned place preference Wang et al., 2010) . These studies suggest that extinction learning involves epigenetic regulation of transcription of certain genes that are essential for long-lasting synaptic plasticity and longterm memory.
In support of an important role of epigenetic regulation of gene transcription in extinction learning, this present study demonstrated that CPA extinction training resulted in significant increases in BDNF gene transcription and BDNF protein expression in the vmPFC of rats. Using ChIP assays, we found that extinction-induced increases in BDNF mRNA expression were associated with increased recruitment of CREB to and acetylation of histone H3 at the promoters of BDNF exon I-containing transcripts in the vmPFC, although Western blot assays showed enhancement of both histone H3 and histone H4 Figure 7 . HDAC inhibitor TSA increased histone acetylation as well as BDNF gene transcription in the vmPFC and promoted extinction of CPA behavior. A, Intra-vmPFC injections of TSA before extinction training increased the levels of AcH3 and AcH4 (n ϭ 6). B, BDNF exon I-and exon IV-containing transcripts were significantly increased within the vmPFC after treatment with TSA (n ϭ 5). C, Injections of TSA into the vmPFC facilitated extinction of CPA behavior (n ϭ 10). D, Schematic representation of injection sites in the vmPFC for rats used in the experiments (OE, TSA; F, Vehicle). Values are expressed as the mean Ϯ SEM. *p Ͻ 0.05, ***p Ͻ 0.001, compared with the corresponding vehicle-microinjected control groups, Student's t test or one-way ANOVA followed by Bonferroni's post hoc test. acetylation in the vmPFC. Discrepantly, a previous study showed that extinction of conditioned fear induced a significant increase in histone H4 acetylation at the promoters of BDNF exon I and IV-containing transcripts in the mPFC (Bredy et al., 2007) . These findings indicate that various extinction paradigms differentially regulate BDNF mRNA expression in the mPFC by exonspecific transcription. Further, we found that intra-vmPFC administration of HDAC inhibitor TSA enhanced extinction-induced histone acetylation as well as BDNF gene transcription in the vmPFC. These results clearly indicate that epigenetic regulation of BDNF gene transcription in the vmPFC is required for the extinction of aversive memory associated with drug withdrawal.
Behavioral consequences of extinctioninduced changes in BDNF transcription within the vmPFC BDNF is essential for learning related synaptic plasticity and the maintenance of long-term memory. The role of BDNF in fear extinction is well established (Chhatwal et al., 2006; Heldt et al., 2007; Kirtley and Thomas, 2010; Peters et al., 2010) . A recent study reported that enhancement of BDNF levels in the IL-mPFC either by direct infusion of BDNF to IL-mPFC or by infusion of BDNF into the hippocampal-IL mPFC pathway induced extinction of fear memory (Peters et al., 2010) . Recent evidence also shows that epigenetic regulation within the vmPFC of BDNF gene transcription correlates with fear extinction (Bredy et al., 2007) . These studies suggest that elevation of BDNF levels in the vmPFC is critical for the extinction of fear behaviors. The present study demonstrated that CPA extinction training resulted in significant increases in BDNF expression in the vmPFC of rats through epigenetic mechanism. Intra-infralimbic subregion of vmPFC infusion of the Trk receptor antagonist K252a or BDNF scavenger TrkB-Fc disrupted extinction of CPA behavior, indicating that BDNF signaling through TrkB receptors in the vmPFC is required for the extinction of aversive memory associated with drug withdrawal. The vmPFC is composed of the IL and the prelimbic (PL) cortex. Substantial evidence suggests that IL and PL have opposite influences on fear and addiction and have different connections to the amygdala and the nucleus accumbens subregions (for review, see Peters et al., 2009 ). The present study provides new evidence in support of a critical role of the vmPFC (infralimbic subregion) in extinction learning and memory by showing that the vmPFC is required for extinction of CPA behavior. Moreover, the present study further suggests that epigenetic regulation of BDNF expression in the vmPFC is critical for extinction of CPA behavior.
Additionally, a great body of evidence indicates that BDNF is critically involved in the regulation of cocaine craving and relapse. BDNF in various brain regions differentially regulates cocaine-seeking behaviors. Increases in BDNF protein levels in the nucleus accumbens (NAc) and the ventral tegmental area (VTA) contribute significantly to cocaine reinforcement and the reinstatement of cocaine seeking (Grimm et al., 2003; Lu et al., 2004; Graham et al., 2007) . In contrast to its role in the NAc and the VTA, exogenous BDNF infusions into the dmPFC suppress the reinstatement of cocaine seeking (Berglind et al., 2007 (Berglind et al., , 2009 McGinty et al., 2010; Whitfield et al., 2011) . A recent study also reported that cocaine self-administration resulted in increased expression of BDNF in the dmPFC and knockdown of such BDNF expression in the dmPFC with shRNA increased the cocaine-taking behavior, suggesting that increases in BDNF transcription in the dmPFC may diminish the reinforcing efficacy of cocaine (Sadri-Vakili et al., 2010) . Correspondingly, we found that augmentation of BDNF expression in the vmPFC extinguished aversive affective memory of drug withdrawal. Given an important role of negative affective memory in the maintenance of drug seeking behavior, our findings may give a possible explanation why increase in BDNF levels in the vmPFC lead to attenuating the reinstatement of drug seeking.
Signaling pathways whereby CPA extinction training induces histone acetylation at BDNF exon I-containing promoters ERK plays an important role in long-term synaptic plasticity (Thomas and Huganir, 2004) and it has been established as a potent regulator of gene transcription in long-term memory formation (Impey et al., 1998; Miller and Marshall, 2005) . Recently, ERK was shown to regulate histone acetylation in hippocampus (Levenson et al., 2004; Chwang et al., 2006; Chandramohan et al., 2008) . Consistently, the current study showed that CPA extinction training induced activation of ERK in the vmPFC. Infusion of ERK inhibitor U0126 into the vmPFC inhibited CPA extinction training-induced enhancement of acetylation of histone H3 at BDNF exon I-containing promoters, indicating that ERK was an important regulator of histone acetylation. CREB is an important downstream effector of ERK in the regulation of gene transcription (Impey et al., 1998; Chwang et al., 2007) . ERK can exert transcriptional regulation effects by controlling the phosphorylation of CREB via mitogen-and stress-activated protein kinase 1 (MSK1) (Brami-Cherrier et al., 2005; Chwang et al., 2007) . CREB is thought to activate transcription through recruiting the coactivator CBP (Hu et al., 1999; Korzus et al., 2004; Pandey et al., 2008) . The recruited CBP has intrinsic histone acetyltransferase activity and can acetylate lysine residues within histones helps to remodel chromatin structure into a form that is accessible to active transcription (Chrivia et al., 1993; Alarcó n et al., 2004) . CBP has been shown to be necessary for long-lasting forms of transcription-dependent synaptic plasticity and long-term memory (Alarcó n et al., 2004; Korzus et al., 2004; Oliveira et al., 2007) .
In this study, we found that CPA extinction training induced CREB phosphorylation and increased the association of phosphorylated CREB with BDNF exon I-containing promoters and that CPA extinction training also induced enhancement of CBP protein expression in the vmPFC, suggestive of the possibility that CPA extinction training-induced histone acetylation may be involved in CREB recruitment of CBP. We further found that infusion of U0126 into the vmPFC suppressed extinctioninduced CREB phosphorylation and the association of phosphorylated CREB with BDNF exon I-containing promoters and disrupted extinction training-induced increase in BDNF gene transcription and decrease in CPA behavior. These results support that ERK-CREB signaling pathways are involved in CPA extinction training-induced chromatin modification. Further, given the observations that infusion of DCS, a NMDA receptor partial agonist, into the vmPFC mimics CPA behavioral extinction which activates ERK and CREB, induces histone acetylation and attenuates CPA behavior, our findings also suggest that CPA extinction training-induced activation of ERK-CREB signaling pathways in the vmPFC may be in a NMDA receptor-dependent manner as reported in the hippocampus by previous studies (Levenson et al., 2004; Chandramohan et al., 2007 Chandramohan et al., , 2008 .
Conclusions
The present study demonstrates that CPA extinction training increases BDNF mRNA expression in the vmPFC through chromatin modification, which is critical for the extinction of aversive memory associated with drug withdrawal. Specifically, following CPA extinction training the chromatin associated with BDNF exon I transcript increases the association with phosphorylated CREB and becomes acetylated, which remodels chromatin structure into a form that is accessible to active transcription. This study also suggests that CPA extinction training-induced chromatin modification of BDNF gene transcription in the vmPFC is trigged by activation of ERK-CREB signaling pathways perhaps in a NMDA receptor-dependent manner. Our results provide the first evidence that chromatin regulation of BDNF transcription in the vmPFC is an important mechanism that is involved in the extinction of aversive memories associated with morphine withdrawal. Our results also define a series of molecular mechanisms whereby extinction training leads to chromatin remodeling. Our findings may facilitate the development of treatments for drug craving and relapse.
